製薬企業におけるマイクロサンプリングの利用状況・意識に関するアンケート調査と今後の課題

谷山 和弘; 飯嶋 康祐; 伊藤 さやか; 岡山 幸誠; 西澤 学; 橋本 雅世; 畠中 俊; 吉井 一良; 田中 誠治; 三浦 慎一

doi:10.14869/toxpt.47.1.0_P-237

The 47th Annual Meeting of the Japanese Society of Toxicology

Session ID : P-237

DOI https://doi.org/10.14869/toxpt.47.1.0_P-237

Conference information

Host: The Japanese Society of Toxicology

Name : The 47th Annual Meeting of the Japanese Society of Toxicology

Date : 2020 -

Poster

Questionnaire survey on the status of use and awareness of microsampling in pharmaceutical companies and future issues

*Kazuhiro TANIYAMA, Kousuke IIJIMA, Sayaka ITO, Takashige OKAYAMA, Manabu NISHIZAWA, Masayo HASHIMOTO, Suguru HATANAKA, Kazuyoshi YOSHII, Seiji TANAKA, Shin-ichi MIURA

Author information

*Kazuhiro TANIYAMA
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Kousuke IIJIMA
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Sayaka ITO
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Takashige OKAYAMA
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Manabu NISHIZAWA
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Masayo HASHIMOTO
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Suguru HATANAKA
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Kazuyoshi YOSHII
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Seiji TANAKA
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association
Shin-ichi MIURA
Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association

CONFERENCE PROCEEDINGS FREE ACCESS

Details

Abstract

We conducted a questionnaire survey to clarify the state of efforts and concerns in microsampling and to disseminate information for the dissemination of microsampling by organizing the information necessary for the effective utilization of microsampling technology in drug development in the future.

The survey was conducted for 60 member companies and received responses from 44 companies. We summarized the responses to the survey and discussed the widespread use of microsampling for TK assessment.

Corresponding author

Register with J-STAGE for free!